Acute Myeloid Leukemia

DBCOND0029883Hemic and Lymphatic DiseasesNeoplasms

Acute Myeloid Leukemia is the indication for 18 drugs in DrugBank. It is covered by 29 curated, structured indications.

Also known as
AML · Acute Myelocytic Leukemia · Acute Myelogenous Leukemia · Acute Myeloid Leukemia (AML) · Acute Myelogenous Leukemia (AML)
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT045793ICD-10C92.0SNOMED CT103689001MedDRA10024291UMLSC0023467

What you can answer from here — as of September 26, 2026

18Indicated drugsWith each drug's targets and mechanism
Listed above
29Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
2,789Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Boxed warningLabel boxed warnings that name this condition
Sign in
24Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Acute Myeloid Leukemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In